-
1دورية أكاديمية
المؤلفون: Kremer Hovinga, Johanna A.1,2, George, James N.3,4 james-george@ouhsc.edu
المصدر: New England Journal of Medicine. 10/24/2019, Vol. 381 Issue 17, p1653-1662. 10p.
مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura, *VON Willebrand disease, *IDIOPATHIC thrombocytopenic purpura
-
2دورية أكاديمية
المؤلفون: Scully, Marie1 m.scully@ucl.ac.uk, Antun, Ana2, Cataland, Spero R.3, Coppo, Paul4, Dossier, Claire5, Biebuyck, Nathalie6, Hassenpflug, Wolf-Achim7, Kentouche, Karim8, Knöbl, Paul9, Kremer Hovinga, Johanna A.10, López-Fernández, M. Fernanda11, Matsumoto, Masanori12, Ortel, Thomas L.13, Windyga, Jerzy14, Bhattacharya, Indranil15, Cronin, Michael15, Hong Li15, Mellgård, Björn15, Patel, Munjal15, Patwari, Parth15
المصدر: New England Journal of Medicine. 5/2/2024, Vol. 390 Issue 17, p1584-1596. 13p.
مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura, *CROSSOVER trials
-
3دورية أكاديمية
المؤلفون: Scully, M.1, Cataland, S. R.2, Peyvandi, F.3, Coppo, P.4, Knöbl, P.5, Hovinga, J. A. Kremer6, Metjian, A.7, de la Rubia, J.8, Pavenski, K.9, Callewaert, F.10, Biswas, D.10, De Winter, H.10, Zeldin, R. K.10 hilde.dewinter@ablynx.com, Scully, Marie11, Cataland, Spero R11, Peyvandi, Flora11, Coppo, Paul11, Knöbl, Paul11, Kremer Hovinga, Johanna A11, Metjian, Ara11
المصدر: New England Journal of Medicine. 1/24/2019, Vol. 380 Issue 4, p335-346. 12p.
مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GINGIVAL hyperplasia, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *PLASMA exchange (Therapeutics), *RESEARCH, *THROMBOTIC thrombocytopenic purpura, *EVALUATION research, *BODY mass index, *RANDOMIZED controlled trials, *BLIND experiment, *PLATELET count, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents
-
4دورية أكاديمية
المؤلفون: Peyvandi, Flora1,2, Scully, Marie3,4, Hovinga, Johanna A. Kremer5,6, Cataland, Spero7, Knöbl, Paul8, Haifeng Wu9, Artoni, Andrea1, Westwood, John-Paul3, Taleghani, Magnus Mansouri5,6, Jilma, Bernd10, Callewaert, Filip11 filip.callewaert@ablynx.com, Ulrichts, Hans12, Duby, Christian11, Tersago, Dominique11, Kremer Hovinga, Johanna A (AUTHOR), Wu, Haifeng (AUTHOR), Mansouri Taleghani, Magnus (AUTHOR), TITAN Investigators (CORPORATE AUTHOR)
المصدر: New England Journal of Medicine. 2/11/2016, Vol. 374 Issue 6, p511-522. 12p.
مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *BLOOD platelet aggregation, *PLASMA exchange (Therapeutics), *TREATMENT effectiveness, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GLYCOPROTEINS, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *RESEARCH funding, *THROMBOTIC thrombocytopenic purpura, *DISEASE relapse, *EVALUATION research, *RANDOMIZED controlled trials, *DISEASE remission, *BLIND experiment, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents